BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5128423)

  • 21. [Physical and exercise therapy of chronic obliterating arteriopathy of the lower limbs: clinical study].
    Galante M; Franchignoni F; Andina A; Grioni G
    Clin Ter; 1982 May; 101(4):357-62. PubMed ID: 7105641
    [No Abstract]   [Full Text] [Related]  

  • 22. [Vasodilator activity of cetiedil in patients with peripheral arterial insufficiency and vasospastic changes: hemodynamic study].
    Matesanz JM; Reina T; García F; Acin F; Méndez B; Tamames S
    Med Clin (Barc); 1982 Sep 1-15; 79(4):173-6. PubMed ID: 7144291
    [No Abstract]   [Full Text] [Related]  

  • 23. [Further trials of a long-acting vasodilator agent in 397 patients with cronic peripheral obliterating arteriopathy of a sclerotic nature].
    Ghezzi P; Cavaliere P; Berti Riboli E
    Minerva Cardioangiol; 1969 May; 17(5):333-6. PubMed ID: 5785731
    [No Abstract]   [Full Text] [Related]  

  • 24. [Preliminary results of prostaglandin E1 therapy in peripheral obliterating arteriopathy].
    Pilger E; Juan H
    Wien Klin Wochenschr; 1983 Apr; 95(8):263-6. PubMed ID: 6683910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical trial of a long-acting vasodilator agent in chronic peripheral obliterating arteriopathy of a sclerotic nature].
    Gemma GB; Ghezzi P; Cavaliere P
    Minerva Cardioangiol; 1969 May; 17(5):324-32. PubMed ID: 5785730
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chemical lumbar sympathectomy in patients with chronic ischemia of the lower extremities].
    Piatko VE; Sukhotin SK
    Anesteziol Reanimatol; 2004; (4):31-3. PubMed ID: 15468551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Our experience with lumbar gangliectomy in treatment of chronic peripheral obliterating arteriopathy of the lower extremities].
    Longhino C; Postiglione G; Portis PA
    Osp Ital Chir; 1968; 19(4):375-94. PubMed ID: 5718566
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of chronic arterial insufficiency of legs with midocalm in elderly].
    Briskin BS; Dibirov MD; Evseev IuN; Novosel'tsev OS
    Khirurgiia (Mosk); 2000; (4):52-4. PubMed ID: 10800314
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative etiology of obliterating arteriopathy of the lower limbs and of coronary arteriopathy].
    Schwartz D; Lellouch J; Anguera G; Richard JL; Beaumont JL
    Rev Atheroscler; 1965; 7():Suppl 3:24-32. PubMed ID: 5885322
    [No Abstract]   [Full Text] [Related]  

  • 30. [Transcutaneous determination of oxygen and carbon dioxide pressure in patients with obliterating atherosclerosis of blood vessels of the lower limbs].
    Shevtsov VI; Shchurova EN; Shchurov VA
    Vestn Khir Im I I Grek; 1999; 158(3):30-3. PubMed ID: 10481879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of patients with obliterating diseases of the arteries of the lower extremities with regional vacuum electrophoresis].
    Buiavykh AG
    Vestn Khir Im I I Grek; 1984 Feb; 132(2):126-7. PubMed ID: 6719709
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study and evaluation of patients with obliterating arteriopathy of the lower limbs: use of isokinetics to analyze muscular strength and fatigue].
    Demonty B; Detaille V; Pasquier AY
    Ann Readapt Med Phys; 2004 Nov; 47(9):597-603. PubMed ID: 15539066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical, oscillographic and plethysmographic comparison before and after medical and surgical treatment of subjects with peripheral obliterating arteriopathy].
    Tardito E; Grassi T
    Minerva Med; 1971 May; 62(39):1971-80. PubMed ID: 5579735
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of patients with obliterating vascular diseases of the extremities].
    Vakhidov VV; Khachiev LG
    Khirurgiia (Mosk); 1968 Dec; 44(12):82-7. PubMed ID: 5711636
    [No Abstract]   [Full Text] [Related]  

  • 35. [Production of lactic acid and acid-base equilibrium in the triangular effort test 10 watts-minute in obliterating arteriopathy of the lower extremities].
    Cherchi A; Raffo M; Maxia L; Verzetti G; Bina M; Fonzo R
    Boll Soc Ital Cardiol; 1969; 14(3):386-99. PubMed ID: 5408187
    [No Abstract]   [Full Text] [Related]  

  • 36. [Submicroscopic changes in the gastrocnemius muscles of subjects with chronic obliterating arteriopathy of the lower extremities].
    Alia EE; Digiesi V; Tota G; Arcangeli P
    Boll Soc Ital Biol Sper; 1970 Jan; 46(1):11-2. PubMed ID: 5419755
    [No Abstract]   [Full Text] [Related]  

  • 37. [Stimulation of lower extremity peripheral circulation in patients with obliterating arteriosclerosis by the wire insertion into the bone marrow canal].
    Ivanov GP; Rechkin Mi; Shchurova EN; Bunov VS; Beloborodov RN
    Vestn Khir Im I I Grek; 2005; 164(5):64-7. PubMed ID: 16768342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Considerations on the activation of the regional fibrinolytic system of the extremities in subjects with obliterating arteriopathy with a malignant course].
    Brunetti S; Tesi M; Caramelli L
    Riv Crit Clin Med; 1967 Dec; 67(6):443-54. PubMed ID: 5603689
    [No Abstract]   [Full Text] [Related]  

  • 39. [Contribution to the therapy of juvenile and arteriosclerotic chronic peripheral obliterating artery diseases with a new sympatholytic drug].
    Stoppani L; Lo Cuoco A
    Minerva Cardioangiol; 1966 Mar; 14(3):163-5. PubMed ID: 5937431
    [No Abstract]   [Full Text] [Related]  

  • 40. [Findings on the use of low molecular weight dextran in arteriopathic patients].
    Mirenda P
    Minerva Cardioangiol; 1968 Jan; 16(1):48-57. PubMed ID: 5741541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.